Posts Tagged ‘Pharmaceutical Companies’

An argument for medical marijuana

July 20, 2016

imrs

On average, physicians in states where medical marijuana is legal prescribe fewer drugs, especially painkillers, than in other states.   The implication is people who smoke pot have less need for painkillers or other prescription drugs.

Addiction to opioid painkillers, such as OxyContin, is a serious problem.  Overuse of psychiatric drugs is another serious problem.  Marijuana can be abused, too, but it is by far less dangerous.

LINK

One striking chart shows why pharma companies are fighting legal marijuana by Christopher Ingraham for The Washington Post.  (Hat tip to Mike the Mad Biologist)

Public Citizen on the Trans Pacific Partnership

April 17, 2015

tpp-nafta-on-steroids-infographicSource: Public Citizen.

Top congressional leaders, including Senators Orrin Hatch, R-Utah, and Ron Wyden, D-Oregon, the chair and vice-chair of the Senate finance committee, and Rep. Paul Ryan, R-Wisconsin, chair of the House ways and means committee, announced their support for “fast track” approval of the Trans Pacific Partnership Agreement.

This would mean that the House would have 60 days to discuss this complicated agreement, and the Senate an additional 30 days, after which they would have to vote the agreement up or down, without amendment.

But the fact that the leaders support fast track doesn’t mean it’s a done deal.  The procedure still must go before the House and Senate as a whole.

I think the TPP is a bad idea, but, even it were a good idea, it deserves more discussion than fast track would allow.

Doctors Without Borders on the TPP

April 17, 2015

tpp_infographic2_0

It is not too late to modify these harmful rules.  Negotiations among the United States and 12 other nations have been  are in the process of being completed, and it is now will then be up to the United States Congress to approve the Trans Pacific Partnership Agreement—or not.

The Electronic Frontier Foundation on the TPP

April 17, 2015

tpp_1Well, it’s too late now to try to influence the negotiations.

Senators Orrin Hatch, R-Utah, and Ron Wyden, D-Oregon, the chair and vice-chair of the Senate finance committee, and Rep. Paul Ryan, R-Wisconsin, the chair of the House ways and means committee, agreed to support fast-track approval for the proposed 12-nation Trans Pacific Partnership Agreement.

This would mean that the House would have 60 days to discuss the agreement, and the Senate would have an additional 30 days, before they voted “yes” or “no”, with no possibility of amendment.

The fact that President Obama and powerful Congressional leaders support fast track does not mean that it has been approved.  The procedure requires a vote of the House and Senate, and, since there is strong opposition in both parties, it may well not be approved.